Toll-like receptor 8 agonists improve NK-cell function primarily targeting CD56^brightCD16⁻ subset

This is a publication. If there is no link to the publication on this page, you can try the pre-formated search via the search engines listed on this page.

Authors: Irene Veneziani; Claudia Alicata; Andrea Pelosi; Nadine Landolina; Biancamaria Ricci; Valentina D'Oria; Anna Fagotti; Giovanni Scambia; Lorenzo Moretta; Enrico Maggi

Journal title: Journal for ImmunoTherapy of Cancer

Journal number: 1

Journal publisher: BMJ

Published year: 2022

DOI identifier: 10.1136/jitc-2021-003385

ISSN: 2051-1426